850 results on '"Coles, Alasdair"'
Search Results
2. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
3. Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study
4. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
5. The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis
6. GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
7. Exploratory analysis of biological age measures in a remyelination clinical trial.
8. Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
9. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
10. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
11. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
12. Susac’s syndrome as an autoimmune complication of alemtuzumab-associated immune reconstitution
13. Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol
14. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
15. Promoting remyelination in multiple sclerosis
16. Neurological Implications of COVID-19 Infections
17. Transcript specific regulation of expression influences susceptibility to multiple sclerosis
18. Quantifying normal human brain metabolism using hyperpolarized [1–13C]pyruvate and magnetic resonance imaging
19. Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial
20. Visual outcome measures in clinical trials of remyelinating drugs
21. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial
22. Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
23. A systematic checklist approach to immunosuppression risk management: An audit of practice at two clinical neuroimmunology centers
24. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
25. Demyelinating disorders of the central nervous system
26. The treatment of matter and divinisation in the Ecclesiastical Hierarchy of pseudo-Dionysius as a basis for evaluating his sacramental theology
27. The Discipline of Neurology
28. Temporal Lobe Epilepsy, Dostoyevsky and Irrational Significance
29. Hyperpolarized 13C MRI: A novel approach for probing cerebral metabolism in health and neurological disease
30. Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series
31. Chasing MOG antibodies down … assays and lumbar punctures
32. Novel paraneoplastic mechanism for cerebellar ataxia in Erdheim-Chester disease
33. Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients
34. E
35. H
36. G
37. I
38. F
39. A
40. B
41. D
42. C
43. XYZ
44. W
45. T
46. U
47. V
48. R
49. P
50. S
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.